🔽European indices fell at the end of the session after several countries suspend use of AstraZeneca's vaccine
At the end of the European session, moods in the stock market worsened due to the negative news regarding coronavirus vaccination. Authorities in Germany, France and Italy today announced they are no longer using AstraZeneca vaccines. In response to these reports, the main stock indices on the Old Continent are trading at their daily lows. The German DAX (DE30) contract is losing more than 1% and is trading below 14,400 points, while the French CAC40 (FRA40) contract fell 0.75% and the Italian FTSE MIB (ITA40) is down 0.2%.
The World Health Organization, however, believes that there is no evidence which would suggest that cases of blood clots are related to the AstraZeneca vaccine, and the UK medicines agency said the vaccine is safe.
Start investing today or test a free demo
Open account Try demo Download mobile app Download mobile appLooking at the technical situation at the DE30, sellers broke below the support at 14,450 pts, which may open the way towards bigger downward correction. As for the H1 interval, the nearest major support is at 14,260 pts and is marked with the lower limit of 1: 1 structure. The local formation of a double peak may herald further declines.
DE30 interval H1. Source: xStation5This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.